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OBJECTIVES The aim of this study was to investigate the morphologic changes in infarct-related lesions
after stenting in acute or recent myocardial infarction (MI) with coronary angioscopy.
BACKGROUND There is no information on the serial morphologic changes, which occur after stenting, and
the time course of neointimal coverage of stents for disrupted unstable plaques.
METHODS Forty-three patients with MI within seven days of onset were examined. Angioscopy was
serially performed for the infarct-related lesions at baseline (n 43), after balloon angioplasty
(n  35), and after stenting following balloon angioplasty (n  39) and at one (n  36) and
six months (n  30) after stenting.
RESULTS At baseline, most of the lesions had complex morphology, yellow plaque color, and protruding
thrombus (96%, 96%, and 74%, respectively). Although balloon angioplasty reduced the
protruding thrombus, it remained in 37%, and an intimal flap was observed in 89% of the
lesions. After stenting, the protruding thrombus and intimal flap disappeared, with an
increased luminal size obtained in all lesions. At one-month follow-up, an irregular and
yellow surface, along with a lining thrombus, was still observed, with partial neointimal stent
coverage in most of the lesions. At six-month follow-up, the neointima was found to have
sufficiently formed over the stent. The plaque shape and color were almost all classified as
smooth (97%) and white (93%).
CONCLUSIONS These results suggest that a stent not only compressed and covered a disrupted plaque with
a protruding thrombus and intimal flap, leading to a wide vessel lumen, but also helped to seal
the unstable plaque through neointimal proliferation. (J Am Coll Cardiol 2003;42:
1558–65) © 2003 by the American College of Cardiology Foundation
Coronary angioscopy is a relatively new technique for
visualizing the intracoronary surface morphology in detail
(1). Recently, angioscopic observations have revealed new
insights that: 1) the characteristics of plaque instability
presenting complex morphology, yellow color, and throm-
bus lasted for one month after myocardial infarction (MI),
even in patients treated with thrombolysis or percutaneous
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transluminal coronary angioplasty (PTCA) (2,3); and 2)
morphologic changes in infarct-related plaque were recog-
nized at one to six months after PTCA, as part of the
healing process evoked by angioplasty. A reduction in the
yellow color and thrombogenicity of the disrupted plaque
was observed through neointimal proliferation, called “an-
gioscopic plaque stabilization” (4,5). However, there is still
no information available on the serial morphologic changes
in infarct-related lesions treated with coronary stents. Com-
pared with balloon angioplasty, the neointimal response to a
stent is more extensive and takes a different form. Little is
known, however, regarding the plaque-stabilizing effect of a
stent in this setting, despite the fact that it is widely used as
one of the most effective revascularization therapies for
patients with MI. The objective of the present study with
angioscopy was to assess the morphologic changes of the
infarct-related lesion occurring in a series of stent placement
procedures in the months after stenting in patients with
acute or recent MI.
METHODS
Patient selection. From October 1997 to December 1999,
208 patients with either acute or recent MI within seven
days of onset were admitted to our institute. The diagnosis
for acute or recent MI was satisfied by the following criteria:
total creatine kinase (CK) or CK-MB greater than twice the
upper limit of our hospital’s laboratory normal, with elec-
trocardiographic (ECG) evidence of MI or ischemic symp-
toms. After examinations, 114 (55%) of the 208 MI patients
underwent emergency percutaneous coronary interventions
of the infarct-related lesion based on the following criteria:
1) continuing ischemic symptoms associated with persistent
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ST-segment elevation of at least 1 mm or more in the
contiguous ECG leads; or 2) evidence of postinfarction
angina (PIA), which was defined as recurrent anginal pain at
rest presenting 24 h after acute MI. This diagnosis also
required the recording of transient ST-segment elevation or
depression of 1 mm or inverted or normalized T waves on
the original ECG leads of the acute MI during an episode
of chest pain.
For 114 patients, angioscopy was performed if the fol-
lowing criteria were met: 1) the infarct-related artery was
clearly identified from the ECGs, echocardiographic wall
motion abnormalities, and coronary angiographic findings;
2) the infarct-related artery was found to be anatomically
suitable for angioscopy according to previously described
criteria (2); 3) both appropriate angioscopy instruments and
sufficiently skilled staff members to perform angioscopy and
staff skilled in angioscopy were available at the time; 4)
patients did not have cardiogenic shock, left main coronary
artery disease, or a history of coronary artery bypass graft
surgery; and 5) written, informed consent for angioscopy
was obtained from the patient. Angioscopy of the infarct-
related lesion was performed in 43 patients with acute or
recent ST-segment elevation MI within seven days of onset.
Angioscopic observations were serially performed at base-
line, immediately after balloon angioplasty with subsequent
stenting, immediately after stenting, at one-month
follow-up (mean 31  9 days, median 31 days), and at
six-month follow-up (mean 224  68 days, median 201
days). This project was approved by the Institutional Review
Board of our hospital.
Stent implantation procedures. All patients were treated
with aspirin (81 mg/day), ticlopidine (100 mg twice daily),
cilostazol (100 mg twice daily for 3 days after admission),
and heparin (5,000 IU intravenously) immediately after
admission. Cilostazol was administered as an antiplatelet
agent, which inhibits platelet aggregation earlier than ticlo-
pidine or aspirin (6). Heparin was administered to maintain
an activated clotting time of 250 s or longer. All stent
implantations were performed after balloon angioplasty by
the femoral approach. Four types of slotted tube or mul-
tidesign stents were used in this study: GFX (Applied
Vascular Engineering, Santa Rosa, California), Multi-link
(Guidant, Advanced Cardiovascular Systems, Santa Clara,
California), NIR (Boston Scientific, Galway, Ireland), and
Palmaz-Schatz (Cordis, Johnson & Johnson, Warren, New
Jersey) stents.
Angioscopic equipment and procedures. Coronary an-
gioscopy was performed with a 4.5F rapid-exchange angio-
scope (Vecmova, Clinical-Supply Corp., Gifu, Japan),
which is compatible with a conventional 0.014-in. angio-
plasty guide wire and an 8F guiding catheter. This angio-
scope system consists of an imaging catheter, a light source,
a color television camera and monitor, and a videotape
recorder. The light source employed is a high-intensity (300
W) xenon light. The angioscope is composed of two
elements (image bundle in delivery catheter). The image
bundle consists of 3,000 optical fibers with a microlens at
the distal tip, which can be independently advanced 6 cm in
front of the delivery catheter. A compliant occlusion balloon
is located at the distal tip of the delivery catheter, which,
when inflated, occludes the anterograde flow during imag-
ing. Warmed physiologic saline was continuously irrigated
through the delivery catheter for the displacement of blood
at a rate of 0.6 to 0.8 ml/s by a power injector, and the
occlusion balloon was gradually hand-inflated until the
image was viewed. When the field of view was flushed clear
of blood, the inflation of the occlusion balloon was con-
stantly maintained. The light intensity was manually ad-
justed to illuminate the dark interior and also to prevent
halation during angioscopic observation. The guiding cath-
eter pressure, ST-segment changes, cardiac rhythm, and
patient comfort were monitored continuously during an-
gioscopy. Each angioscopic image acquisition took from 15
to 25 s, and all sequences were recorded on s-VHS video-
tape for subsequent analysis. In performing pre-intervention
angioscopy, the angioscopic catheter was not passed
through the distal site of the infarct-related lesion, in order
to avoid either injuring or destroying the plaque and
thrombus. The average duration for one angioscopic proce-
dure was 13 min. The average amount of infused saline was
15.6 ml per one angioscopic procedure.
Angiographic analysis. Initial and postprocedural flow in
the infarct-related artery was graded according to the
Thrombolysis In Myocardial Infarction (TIMI) trial classi-
fication. Quantitative angiographic measurements of the
lesion were performed by using digital angiograms that were
analyzed off-line with an automated edge-detection system
(CMS, Medis Medical Imaging System, Nuenen, The
Netherlands). The minimum luminal diameter, reference
diameter, and percent diameter stenosis were measured
from end-diastolic frames and the projection that demon-
strated the highest stenotic site. The measurement of the
reference vessel diameter was made at the proximal part of
the vessel nearest the initial stenotic or occluded lesion. We
routinely perform angiography in at least two projections
after the intracoronary injection of nitroglycerin (0.1 mg).
Total occlusion was defined as TIMI flow grade 0 or 1.
Total occlusion was assigned a value of 0 mm for minimum
luminal diameter and 100% for percent diameter stenosis.
Restenosis was defined as an increase in percent stenosis to
50%.
Angioscopic analysis. Angioscopic definitions were based
on an angioscopic classification system developed by the
European Working Group on Coronary Angioscopy (7), as
Abbreviations and Acronyms
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1559JACC Vol. 42, No. 9, 2003 Sakai et al.
November 5, 2003:1558–65 A Serial Angioscopy Study
well as our previous studies (8,9). A thrombus was defined
as: 1) a coalescent red, white, or mixed color; and 2) a
superficial (lining) or protruding mass adhering to the vessel
wall. The shape of the plaque was classified as smooth
plaque if a segment of a normal-appearing wall was visual-
ized; complex plaque was defined when the surface had a
rough, ulcerated, or irregular appearance with ragged,
cracked, and fissured edges. An intimal flap was defined as
visible cracks or fissures on the luminal surface or large and
thick structures protruding into the lumen (large surface
disruptions), except for small, thin, and free fronds of tissue.
The predominant color of the plaque was classified as white
or yellow. The extent of neointimal stent coverage was
semiquantitatively evaluated using a 5-point scoring system:
0 complete exposure of stent struts; 1 exposure of stent
struts with partial coverage; 2  50% coverage; 3 
almost complete coverage with slightly visible stent struts;
and 4  complete coverage.
The angioscopic results were separately reviewed by two
experienced angioscopists who were unaware of either the
angiographic or clinical findings. In case of any disagree-
ment, a third observer evaluated the angioscopic images,
and consensus was obtained by discussion. Intra-observer
agreement was measured by having an observer repeat the
assessment of 20 angioscopic images (presented in random
order) after one week. The inter-observer agreement was
measured by comparing the assessment of 20 angioscopic
images by two observers. The rate of intra- and inter-
observer agreements for the evaluated angioscopic items
(protruding thrombus, intimal flap, complex plaque, and
yellow plaque) were both 95%. The kappa values for
intra-observer agreement of a protruding thrombus, intimal
flap, complex plaque, and yellow plaque were 1.00, 0.78,
0.90, and 0.90, respectively. In addition, the kappa values
for inter-observer agreement of those items were 1.00, 0.74,
0.90, and 0.89, respectively.
Statistical analysis. The data are presented as the mean
value  SD. Differences between proportions were assessed
by chi-square analysis. Continuous variables were compared
using the unpaired Student t test and one-way analysis of
variance with concomitant Fischer protected least signifi-
cant difference and Scheffe´ F tests. Statistical significance
was accepted at p  0.05. The baseline clinical and
angiographic characteristics and procedural details are de-
scribed in Tables 1 and 2.
RESULTS
Angioscopy procedures (Fig. 1). In 4 (9%) of 43 patients,
angioscopy could not be successfully performed at baseline.
It was impossible to deliver the angioscopy catheter in one
of four patients or to visualize the entire circumference of
Table 1. Clinical Characteristics
Total
(n  43)
Acute MI
(n  28)
PIA
(n  15) p Value
Age (yrs) 61  11 61  11 62  9 0.95
Men 32 (74%) 21 (75%) 11 (73%) 0.91
Hypertension 15 (35%) 9 (32%) 6 (40%) 0.61
Diabetes mellitus 18 (42%) 11 (39%) 7 (47%) 0.64
Hyperlipidemia 29 (67%) 17 (61%) 12 (80%) 0.20
Current smokers 29 (67%) 17 (61%) 12 (80%) 0.20
Previous MI 3 (7%) 3 (11%) 0 0.19
Killip class I/II on admission 26 (93%)/2 (7%) 26 (93%)/2 (7%) 11 (73%)/4 (27%) 0.08
Previous thrombolysis (t-PA) 19 (44%) 13 (46%) 6 (40%) 0.69
Non–Q-wave MI 1 (2%) 1 (4%) 0 —
Interval from acute MI onset
to catheterization (h)
Median 17 15 77  0.0001
6 8 (19%) 8 (29%) —
6  12 4 (9%) 4 (14%) —
12  24 12 (28%) 12 (43%) —
24  48 6 (14%) 4 (14%) 2 (13%)
48  72 3 (7%) — 3 (20%)
72 10 (23%) — 10 (67%)
Medications
Beta-blockers 15 (35%) 10 (36%) 5 (33%) 0.88
ACE inhibitors 19 (44%) 11 (39%) 8 (53%) 0.38
Nitrate 10 (23%) 7 (25%) 3 (20%) 0.71
Calcium blockers 10 (23%) 6 (21%) 4 (27%) 0.70
Antiplatelet drugs 43 (100%) 28 (100%) 15 (100%) 1.00
Lipid-lowering drugs 29 (67%) 19 (68%) 10 (67%) 0.94
Data are presented as the mean value  SD or number (%) of subjects. 6 12 means more than or equal to 6 h, and less than
12 h; 12 24 means more than or equal to 12 h, and less than 24 h; 24 48 means more than or equal to 24 h, and less
than 48 h; 48 72 means more than or equal to 48 h, and less than 72 h.
ACE  angiotensin-converting enzyme; MI  myocardial infarction; PIA  postinfarction angina; t-PA  tissue-type
plasminogen activator.
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the target lesion in the other three patients, because of
tortuous or angular vessels. For 39 patients, angioscopic
observations were obtained for 39 lesions at baseline, for 35
lesions immediately after balloon angioplasty, for 39 lesions
immediately after stenting, for 36 lesions at one-month
follow-up, and for 30 lesions at six-month follow-up.
Angiographic findings. Improvement in TIMI flow grade
3 after balloon angioplasty and stenting was achieved in 38
(88%) and 41 (95%) of 43 patients, respectively. In two
patients, “no reflow” was observed immediately after stent-
ing. The percent diameter stenosis was significantly reduced
from 83  22% at baseline to 55  28% after balloon
angioplasty (p  0.01) and to 7  7% after stenting (p 
0.01). The percent diameter stenosis at one- and six-month
follow-up were 12  9% and 25  23%, respectively (p 
0.01). Restenosis at the six-month follow-up was noted in 6
(20%) of 30 patients.
Comparison of baseline angioscopic characteristics be-
tween acute MI and PIA (Table 3). There was no
difference in the color of thrombus between acute MI and
PIA. However, a higher frequency of protruding thrombus
was observed in patients with acute MI (85% in acute MI vs.
54% in PIA, p  0.038). The plaque shape and color did
not differ between acute MI and PIA.
Angioscopic morphologic changes before and after sten-
ting. THROMBUS AND INTIMAL FLAP (FIG. 2). At baseline,
thrombus was seen in all lesions. The thrombus was
classified as a protruding thrombus in 29 (74%) and a lining
thrombus in 10 lesions (26%). The color of the thrombus
was red in seven (18%), mixed in 28 (72%), and white in
four (10%) (Table 3). After balloon angioplasty, the pro-
truding thrombus significantly decreased compared with
baseline (37% vs. 74%, p  0.01). Immediately after
stenting, the protruding thrombus was completely resolved
Table 2. Baseline Angiographic Characteristics and Stent Implantation Procedures
Total
(n  43)
Acute MI
(n  28)
PIA
(n  15) p Value
Infarct-related artery 0.42
RCA 16 (37%) 9 (32%) 7 (47%)
LAD 23 (54%) 17 (61%) 6 (40%)
LCx 4 (9%) 2 (7%) 2 (13%)
TIMI flow grade 0.40
0/1 17 (40%)/2 (4%) 13 (46%)/1 (4%) 4 (27%)/1 (7%)
2/3 5 (12%)/19 (44%) 4 (14%)/10 (36%) 1 (7%)/9 (60%)
Quantitative angiographic measurements
Reference diameter (mm) 3.37  0.77 3.39  0.45 3.31  0.45 0.86
Minimal luminal diameter (mm) 0.43  0.57 0.43  0.56 0.43  0.66 0.99
Percent stenosis 83  22 83  23 83  22 0.96
Balloon angioplasty
Maximum balloon size (mm) 2.88  0.31 2.87  0.32 2.90  0.28 0.73
Maximum pressure (atm) 9.0  1.5 9.1  1.4 8.7  1.4 0.41
Stent implantation
Reason for stenting 0.58
Planned 31 (72%) 17 (61%) 14 (93%)
Suboptimal result 7 (16%) 7 (25%) 0
Bail-out use 5 (12%) 4 (14%) 1 (7%)
Type of implanted stent
Palmaz-Schatz 6 (14%) 3 (11%) 3 (20%)
Multi-link 12 (28%) 10 (36%) 2 (13%)
NIR 10 (23%) 7 (25%) 3 (20%)
GFX 15 (35%) 8 (29%) 7 (47%)
Stent length (mm) 17.6  3.8 16.9  3.5 18.8  4.1 0.11
Maximum balloon size postdilation (mm) 3.56  0.42 3.55  0.43 3.57  0.42 0.92
Maximum pressure postdilation (atm) 13.1  2.6 12.9  2.8 13.4  2.3 0.58
Data are presented as the number (%) of patients or mean value  SD.
LAD  left anterior descending coronary artery; LCx  left circumflex coronary artery; RCA  right coronary artery;
TIMI  Thrombolysis In Myocardial Infarction; other abbreviations as in Table 1.
Figure 1. Coronary angioscopy procedures. *Failure of the angioscopy
procedure was defined as when the angioscope could not visualize the
entire circumference of the target lesion in order for it to be adequately
evaluated or if it could not reach to the target lesion because of a tortuous
proximal vessel.
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(p 0.01), and a lining thrombus was seen in all lesions. At
one-month follow-up, a lining thrombus was observed in 33
(92%) of 36 lesions, whereas it was seen in 4 (13%) of 30
lesions at six-month follow-up (p  0.01).
The plaque shape and color were assessable in 28 of the
39 lesions at baseline. In the 11 remaining lesions, it was
impossible to assess the plaque because an occlusive throm-
bus was occupying the lumen.
At baseline, complex and yellow plaque was observed in
27 lesions (96%) and an intimal flap was seen in 13 (46%) of
28 assessable lesions. After balloon angioplasty, an intimal
flap was observed in 31 (89%) of 35 lesions and was more
frequently observed after balloon angioplasty than at base-
line (89% vs. 46%, p  0.01). After stenting, the flap
disappeared in all lesions.
PLAQUE SURFACE AND COLOR (FIG. 3). The plaque surface
was defined as irregular in all and as yellow in 38 (97%) of
39 lesions immediately after stenting. At the one-month
follow-up, an irregular surface and yellow color were still
observed through the stent struts in 29 (81%) and 34 (94%)
of 36 lesions, respectively. At six-month follow-up, the
plaque surface was classified as smooth in 29 (97%) and the
plaque color as white in 28 (93%) of 30 lesions. An irregular
shape and yellow color were observed in only one (3%) and
two (7%) lesions.
Stent coverage (Fig. 4). In 36 assessed lesions at one-
month follow-up, a coverage score of 0 was observed in one
lesion (3%), whereas a score of 1 was observed in 25 (69%),
a score of 2 in eight (22%), and a score of 3 in two (6%)
lesions. In 30 assessed lesions at six-month follow-up, a
coverage score of 4 was observed in 24 lesions (80%), a score
of 3 in 5 lesions (17%), and a score of 2 in 1 lesion (3%). The
Figure 2. Changes in the incidence of thrombus and intimal flap. The
intimal flap was assessable in 28 of 39 lesions at baseline. In the 11
remaining lesions, the intimal flap could not be seen because it occupied the
lumen due to occlusive thrombus. *p  0.01 vs. protruding thrombus at
baseline. †p  0.01 vs. protruding thrombus immediately after balloon
angioplasty. #p  0.01 vs. lining thrombus immediately after stenting. ‡p
 0.01 vs. intimal flap immediately after balloon angioplasty. Solid bars
protruding thrombus; hatched bars  lining thrombus; open bars 
intimal flap.
Table 3. Baseline Angioscopic Findings
Total
(n  39)
Acute MI
(n  26)
PIA
(n  13)
p
Value
Thrombus 39 (100%) 26 (100%) 13 (100%)
Size
Lining 10 (26%) 4 (15%) 6 (46%) 0.038
Protruding 29 (74%) 22 (85%) 7 (54%)
Color 0.42
Red 7 (18%) 6 (23%) 1 (8%)
Mixed 28 (72%) 18 (70%) 10 (77%)
White 4 (10%) 2 (8%) 2 (15%)
Plaque*
Shape
Smooth 1 (2.5%) 1 (4%) 0 0.65
Complex 27 (69%) 17 (65%) 10 (77%)
Color
White 1 (2.5%) 1 (4%) 0 0.65
Yellow 27 (69%) 17 (65%) 10 (77%)
*Plaque surface and color were assessable in 28 of the 39 lesions at baseline. In the 11
remaining lesions, it was impossible to assess the plaque because the thrombus
occupied the lumen. Data are presented as the number (%) of subjects.
Abbreviations as in Table 1.
Figure 3. Changes in the plaque surface (A) and color (B) after stenting.
*p  0.01 vs. immediately after stenting and one-month follow-up.
Figure 4. Changes in the stent coverage score after stenting. Data are
presented as the mean value  SD.
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stent coverage score significantly increased at six-month
follow-up compared with one-month follow-up (1.3  0.6
vs. 3.8  0.5, p  0.01).
Clinical outcome. In our series, no major cardiac events
(death, reinfarction, and urgent revascularization for recur-
rent ischemia) occurred during follow-up. At one-month
follow-up, no reocclusion or restenosis were recognized in
any cases. At six-month follow-up, no patient presented
with an unstable coronary syndrome. However, restenosis
was observed in 6 (16%) of 30 eligible patients for angio-
graphic and angioscopic follow-up, and target lesion revas-
cularization was performed for 2 patients (6%) with asymp-
tomatic restenosis A representative example case is shown in
Figure 5.
DISCUSSION
This study represented the first serial assessment by coro-
nary angioscopy to evaluate the short- and inter-mediate-
term results of stent implantation for unstable plaque.
Baseline characteristics of infarct-related lesion. Despite
the fact that our population was composed of a heteroge-
neous group of MI patients at the time of angioscopic
observation at baseline, the morphologic aspect of infarct-
related lesions showed plaque instability demonstrating a
complex morphology, yellow color, and thrombus in the
majority of patients. In addition, patients with PIA, as well
as those with acute MI, had a high prevalence of massive
thrombus. Shapiro et al. (10) reported that thrombolysis
effectively restored the flow on angiography, accompanied
with a resolution of angina in some patients with PIA.
Based on our data, it might be reasonable that thrombolysis
in patients with PIA was effective to improve the flow of the
infarct-related artery.
Early morphologic changes after stenting. Despite the
fact that balloon angioplasty resulted in a significant reduc-
tion in thrombus size, a protruding thrombus was still
present in 37% of the lesions. Furthermore, the vessel
surfaces were found to have evidence of extensive intimal
damage, with a flap at the angioplasty site in almost all
lesions. The extent of the damage was distinctly higher after
balloon angioplasty than at baseline. These intra-luminal
structures may contribute to high rates of an early adverse
outcome after balloon angioplasty for unstable coronary
disease (11). In fact, some investigators reported that
angioscopic thrombus was strongly associated with PTCA
complications (12,13); in particular, a protruding thrombus
was a high risk factor for reocclusion and restenosis (14).
However, the majority of abrupt occlusions after PTCA
were due to dissections and flaps (15). In our series,
however, no adverse outcome was observed in any patients,
despite the fact that a lining thrombus was seen in almost all
patients immediately after stenting. This difference might
be due to differences in the coronary intervention method.
All of our patients underwent stent implantation. On the
other hand, a non-stent coronary intervention was per-
formed in the previous studies. Our angioscopic study
demonstrated that a subsequent stent placement completely
compressed and covered a protruding thrombus and intimal
flap, potentially causing an adverse outcome and resulting in
an increased size of the vessel lumen. This finding may be
one of the favorable effects of stenting.
Angioscopic follow-up after stenting. At one-month
follow-up, a thrombus, irregular surface, and yellow color
were still observed at the stented lesions. This finding
suggested that the plaque instability seen on angioscopy
lasted for at least one month, even after stenting. Neointi-
mal stent coverage was nearly completed by about six
months after stenting. Surprisingly, a thrombus was still
presented in some cases, even at six-month follow-up.
Several possible explanations can be offered for the presence
Figure 5. Serial angioscopic images. (A) At baseline, a protruding mixed thrombus was seen. (B) Immediately after balloon angioplasty, a protruding
thrombus and intimal flap were seen. (C) Immediately after stenting, a wide vessel lumen was obtained by the stent. (D) At one-month follow-up, a lining
thrombus was seen. (E) At one-month follow-up, there was partial neointimal coverage (coverage score 1). (F) At six-month follow-up, there was smooth
and white plaque (coverage score  4) without thrombus. F  intimal flap; GW  guide wire; L  lumen; YP  yellow plaque; T  thrombus.
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of a residual thrombus. Sakatani et al. (16) reported an
interesting case in which the implanted stent was com-
pletely exposed, along with a thrombus, even at 16 months
after stenting. They speculated that the development of
neointimal proliferation might be retarded because of a poor
stent apposition to the vessel wall. Similarly, an inadequate
stent apposition might cause incomplete neointimal cover-
age with thrombus in some of our patients. Second, some of
these lesions could also have had a wall hemorrhage rather
than a thrombus. Third, the tissue factor contained in the
neointima may be responsible for luminal surface thrombo-
genicity, when neointimal proliferation was the most active
at six months after stenting.
Late morphologic changes after stenting. Stable plaque
has a thick fibrous cap consisting of smooth muscle cells
overlying the lipid core. Although these lesions may be
clinically silent or cause angina, they rarely rupture or
precipitate life-threatening events. In contrast, a fibrous cap
in unstable plaque is thin and contains a few smooth muscle
cells. This plaque is prone to rupture, thus leading to the
development of life-threatening acute coronary syndrome.
Concerning the relationship between plaque color and
histologic assessment of plaque, yellow plaque is considered
to be atheromatous plaque, which consists of a large lipid
pool with a thin fibrous cap. White plaque, in contrast, is
fibrous plaque with a thick fibrous cap (17,18). An experi-
mental study showed that the yellow of the plaque color on
angioscopy was dependent on the cap thickness overlying
the lipid core (19). Indeed, yellow plaques were very
common in acute coronary syndromes, and many sites of
disrupted plaques were observed in yellow plaques
(2,3,9,20). Therefore, yellow plaque can be considered as
unstable plaque, whereas white plaque is stable.
In this study, although most of patients had angioscopic
characteristics of plaque instability before stenting, the
appearance at six months after stenting was almost com-
pletely stable plaque, which was observed as smooth white
plaque without thrombus, whether restenosis was present or
not. And no patient presented with an acute coronary
syndrome during follow-up. This change (angioscopic
plaque stabilization) is due to the fact that the stent, which
sealed off the disrupted plaque, was covered completely by
neointimal proliferation. Angioscopic plaque stabilization
may be supportive of the finding and speculation of Ruygrok
et al. (21), that one of the predictors of asymptomatic
restenosis at six-month follow-up after stenting was unsta-
ble angina at the initial presentation, and that stents might
possibly have a plaque-stabilizing effect in acute coronary
syndromes, respectively. Such a stent may also have a
plaque-healing effect similar to balloon angioplasty (4,5).
This may support the proposal of smooth muscle cell
proliferation as a therapy for plaque stabilization (22,23).
Due to this fact, it is not surprising that some randomized
studies comparing stenting with balloon angioplasty in
patients with acute MI have failed to show a reduction in
the rate of reinfarction or death, even though stenting had
a lower incidence of restenosis and revascularization than
balloon angioplasty (24,25). However, it remains unclear as
to whether such angioscopic plaque stabilization is directly
linked to clinical stabilization or not. Indeed, pathologic
studies have demonstrated that neointimal growth after
stenting is associated with a high degree of arterial injury
and inflammation (26).
Study limitations. Several limitations of this study should
be considered. First, our study population consisted of
selected patients. Our inclusion criteria limited the number
of patients who could be studied. The small number of
patients may not be representative of all patients with acute
or recent MI. However, it is noteworthy that the serial
angioscopic observations have disclosed the macromorpho-
logic changes of stenting for unstable plaque. Second, this
study lacked of a contemporary group of patients treated
with balloon angioplasty for a comparison purpose. Based
on our institutional policy, more than 85% of patients with
acute or recent MI in whom percutaneous coronary inter-
ventions were performed were treated with stenting in our
hospital. Therefore, the impact of stenting could only be
inferred by a comparison with the findings of previous
reports. Ueda et al. (5) reported that 80% of infarct-
related plaques still had a yellow color, even at six months
after PTCA. The angioscopic plaque-stabilizing effect of
stenting may appear more rapidly than that of PTCA.
Finally, we could not confirm whether or not angioscopic
plaque stabilization (smooth and white appearance without
thrombus) was linked to clinical stabilization in the present
study. Further study is needed to prove that angioscopic
plaque stabilization correlates to clinical stabilization.
Conclusions. This angioscopic study demonstrated that
the morphologic changes after stenting for unstable plaque
were the following: 1) a stent compressed and covered a
disrupted yellow plaque, with a protruding thrombus and
intimal flap, leading to a wide vessel lumen; and 2) the stent
induced angioscopic plaque stabilization (smooth and white
and without thrombus) through neointimal proliferation,
and the sealing was achieved at about six months after
stenting, accompanied with complete neointimal stent cov-
erage. Thus, a stent is like “a bandage on a wound.” We
suggest that mechanical plaque sealing by stenting may
therefore be a potentially effective therapeutic strategy for
achieving plaque stabilization.
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